Antimicrobial stewardship challenges during the COVID-19 pandemic: implications of antibiotic overuse and antimicrobial resistance
By: Marija Špelić and Vladimir Krajinović
References
- World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Geneva: WHO; 2023.
- World Health Organization. Global Action Plan on Antimicrobial Resistance. Geneva: WHO; 2015.
- Knight GM, Glover RE, McQuaid CF, Olaru ID, Gallandat K, Leclerc QJ, Fuller NM, Willcocks SJ, Hasan R, van Kleef E, Chandler CI. Antimicrobial resistance and COVID-19: Intersections and implications. Elife 2021;10:e64139. doi: 10.7554/eLife.64139
- Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, Satta G, Cooke G, Holmes A. Bacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis 2020;71:2459–68. doi: 10.1093/cid/ciaa530
- Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy JR, Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect 2020;26:1622–9. doi: 10.1016/j.cmi.2020.07.016
- Kariyawasam RM, Julien DA, Jelinski DC, Larose SL, Rennert-May E, Conly JM, Dingle TC, Chen JZ, Tyrrell GJ, Ronksley PE, Barkema HW. Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021). Antimicrob Resist Infect Control 2022;11(1):45. doi: 10.1186/s13756-022-01085-z
- Buehrle DJ, Wagener MM, Nguyen MH, Clancy CJ. Trends in Outpatient Antibiotic Prescriptions in the United States During the COVID-19 Pandemic in 2020. JAMA Netw Open 2021;4(9):e2126114. doi: 10.1001/jamanetworkopen.2021.26114
- Vaughn VM, Gandhi TN, Petty LA, Patel PK, Prescott HC, Malani AN, Ratz D, McLaughlin E, Chopra V, Flanders SA. Empiric antibacterial therapy and community-onset bacterial coinfection in patients hospitalized with Coronavirus disease 2019 (COVID-19): a multi-hospital cohort study. Clin Infect Dis 2021;72:e533–41. doi: 10.1093/cid/ciaa1239
- Guisado-Gil AB, Infante-Domínguez C, Peñalva G, Praena J, Roca C, Navarro-Amuedo MD, Aguilar-Guisado M, Espinosa-Aguilera N, Poyato-Borrego M, Romero-Rodríguez N, Aldabó T, Salto-Alejandre S, Ruiz-Pérez de Pipaón M, Lepe JA, Martín-Gutiérrez G, Gil-Navarro MV, Molina J, Pachón J, Cisneros JM; On behalf of The PRIOAM team. Impact of the COVID-19 pandemic on antimicrobial consumption and hospital-acquired candidemia and multidrug-resistant bloodstream infections. Antibiotics (Basel) 2020;9(11):816. doi: 10.3390/antibiotics9110816
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi: 10.1136/bmj.n71
- COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21. Lancet 2022;399:1513–36. doi: 10.1016/S0140-6736(21)02796-3
- Granata G, Petrosillo N, Al Moghazi S, Caraffa E, Puro V, Tillotson G, Cataldo MA. The burden of Clostridioides difficile infection in COVID-19 patients: A systematic review and meta-analysis. Anaerobe 2022;74:102484. doi: 10.1016/j.anaerobe.2021.102484
- Klein EY, Monteforte B, Gupta A, Jiang W, May L, Hsieh YH, Dugas A. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses 2016;10:394–403. doi: 10.1111/irv.12398
- Alshaikh FS, Godman B, Sindi ON, Seaton RA, Kurdi A. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis. PLoS One 2022;17(8):e0272375. doi: 10.1371/journal.pone.0272375. Erratum in: PLoS One 2024;19(7):e0307695. doi: 10.1371/journal.pone.0307695
- RECOVERY Collaborative Group. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2021;397:605–12. doi: 10.1016/S0140-6736(21)00149-5
- Pham SN, Hori TM, Shafiq A. Pharmacist-led antimicrobial stewardship and antibiotic use in hospitalized patients with COVID-19. Fed Pract 2023;40(6)a:178–81. doi: 10.12788/fp.0380
- Granata G, Cicalini S. The evolving challenge of appropriate antibiotics use in hospitalized COVID-19 patients: a systematic literature review. Antibiotics (Basel) 2024;13(6):545. doi: 10.3390/antibiotics13060545
- AlBahrani S, Almogbel F, Alanazi W, Almutairi SH, Alanazi M, Maximos S, Azaiez F, Osman A, Almuthen S, Jebakumar AZ, Al-Tawfiq JA. Carbapenem use correlates with percentage of patients with COVID-19 in intensive care units. Infection 2023;51:331–6. doi: 10.1007/s15010-022-01867-y
- Kusuma IY, Pratiwi H, Pitaloka DAE. Role of pharmacists in antimicrobial stewardship during COVID-19 outbreak: a scoping review. J Multidiscip Healthc 2022;15:2605–14. doi: 10.2147/JMDH.S385170
- European Centre for Disease Prevention and Control. Antimicrobial consumption in the EU/EEA (ESAC-Net) – Annual Epidemiological Report for 2022. Stockholm: ECDC; 2023 [displayed 12 August 2026]. Available at
https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-consumption-europe-2022 - Vats K, Singh K, Oommen S. Impact of COVID-19 on antibiotic stewardship, antimicrobial resistance, and prescribing habits at two general hospitals in Abu Dhabi: a retrospective analysis. Cureus 2024;16(9):e69170. doi: 10.7759/cureus.69170
- Scott H, Zahra A, Fernandes R, Fries BC, Thode HC Jr, Singer AJ. Bacterial infections and death among patients with Covid-19 versus non Covid-19 patients with pneumonia. Am J Emerg Med 2022;51:1–5. doi: 10.1016/j.ajem.2021.09.040
- Ruiz-Garbajosa P, Cantón R. COVID-19: Impact on prescribing and antimicrobial resistance. Rev Esp Quimioter 2021;34(Suppl 1):63–8. doi: 10.37201/req/s01.19.2021
- Musuuza JS, Watson L, Parmasad V, Putman-Buehler N, Christensen L, Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis. PLoS One 2021;16(5):e0251170. doi: 10.1371/journal.pone.0251170
- Chen JZ, Hoang HL, Yaskina M, Kabbani D, Doucette KE, Smith SW, Lau C, Stewart J, Remtulla S, Zurek K, Schultz M, Koriyama-McKenzie H, Cervera C. Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial. Lancet Infect Dis 2023;23:673–82. doi: 10.1016/S1473-3099(22)00832-5
- Hughes S, Troise O, Donaldson H, Mughal N, Moore LSP. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Clin Microbiol Infect 2020;26:1395–9. doi: 10.1016/j.cmi.2020.06.025
- Rabbi F, Banfield L, Munir M, Chagla Z, Mayhew A, de Souza RJ. Overprescription of antibiotics for treating hospitalized COVID-19 patients: A systematic review & meta-analysis. Heliyon 2023;9(10):e20563. doi: 10.1016/j.heliyon.2023.e20563
- Calderon M, Gysin G, Gujjar A, McMaster A, King L, Comandé D, Hunter E, Payne B. Bacterial co-infection and antibiotic stewardship in patients with COVID-19: a systematic review and meta-analysis. BMC Infect Dis 2023;23(1):14. doi: 10.1186/s12879-022-07942-x
- Langford BJ, Soucy JR, Leung V, So M, Kwan ATH, Portnoff JS, Bertagnolio S, Raybardhan S, MacFadden DR, Daneman N. Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis. Clin Microbiol Infect 2023;29(3):302–9. doi: 10.1016/j.cmi.2022.12.006
- Migliara G, Baccolini V, Isonne C, Cianfanelli S, Di Paolo C, Mele A, Lia L, Nardi A, Salerno C, Caminada S, Cammalleri V, Alessandri F, Tellan G, Ceccarelli G, Venditti M, Pugliese F, Marzuillo C, De Vito C, De Giusti M, Villari P. Prior antibiotic therapy and the onset of healthcare-associated infections sustained by multidrug-resistant Klebsiella pneumoniae in intensive care unit patients: a nested case-control study. Antibiotics (Basel) 2021;10(3):302. doi: 10.3390/antibiotics10030302
- Linn KZ, Sutjipto S, Ng OT, Teo J, Cherng BPZ, Tan TY, Pada SK, Ooi ST, Smitasin N, Thoon KC, Huan X, De PP, Chan D, Tee NWS, Ang M, Hsu LY, Lin RTP, Ng TY, Deepak RN, Koh TH, Apisarnthanarak A, Ponnampalavanar S, Venkatachalam I, Marimuthu K. Impact of COVID-19 pandemic on carbapenem-resistant Enterobacterales incidence in the South-East Asia region: an observational study. Antimicrob Steward Healthc Epidemiol 2023;3(1):e208. doi: 10.1017/ash.2023.477
- Tomczyk S, Taylor A, Brown A, de Kraker MEA, El-Saed A, Alshamrani M, Hendriksen RS, Jacob M, Löfmark S, Perovic O, Shetty N, Sievert D, Smith R, Stelling J, Thakur S, Vietor AC, Eckmanns T; WHO AMR Surveillance and Quality Assessment Collaborating Centres Network. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey. J Antimicrob Chemother 2021;76:3045–58. doi: 10.1093/jac/dkab300
- Nori P, Cowman K, Chen V, Bartash R, Szymczak W, Madaline T, Punjabi Katiyar C, Jain R, Aldrich M, Weston G, Gialanella P, Corpuz M, Gendlina I, Guo Y. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infect Control Hosp Epidemiol 2021;42:84–8. doi: 10.1017/ice.2020.368
- Jorgensen SCJ, Brown K, Clarke AE, Schwartz KL, Maxwell C, Daneman N, Kwong JC, MacFadden DR. The effect of COVID-19 vaccination on outpatient antibiotic prescribing in older adults: a self-controlled risk-interval study. Clin Infect Dis 2024;79:375–81. doi: 10.1093/cid/ciae182
- Politis M, Chatzichristodoulou I, Mouchtouri VA, Rachiotis G. COVID-19 vaccination and use of antibiotics in COVID-19 patients: a systematic review and meta-analysis. Infect Prev Pract 2025;7(3):100461. doi: 10.1016/j.infpip.2025.100461
- World Health Organization. Wastewater and environmental surveillance summary for antimicrobial resistance, Pilot version, 1 December 2025 [displayed 12 August 2026]. Available at
https://cdn.who.int/media/docs/default-source/wash-documents/wash-related-diseases/wes-summary-for-amr---final-1-dec.pdf - Uluseker C, Kaster KM, Thorsen K, Basiry D, Shobana S, Jain M, Kumar G, Kommedal R, Pala-Ozkok I. A review on occurrence and spread of antibiotic resistance in wastewaters and in wastewater treatment plants: mechanisms and perspectives. Front Microbiol 2021;12:717809. doi: 10.3389/fmicb.2021.717809
- Ebrahimzadeh Sarvestani M, Bonato T, Phillips AJ, Pal T, Di Maria F. Antibiotics in wastewater and removal efficiency of treatment plants: A systematic review. Sci Total Environ 2026;1036:181868. doi: 10.1016/j.scitotenv.2026.181868
- Maataoui N, Chemali L, Patrier J, Tran Dinh A, Le Fèvre L, Lortat-Jacob B, Marzouk M, d'Humières C, Rondinaud E, Ruppé E, Montravers P, Timsit JF, Armand-Lefèvre L. Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit. Eur J Clin Microbiol Infect Dis 2021;40:2227–34. doi: 10.1007/s10096-021-04213-6
- Olsen SJ, Winn AK, Budd AP, Prill MM, Steel J, Midgley CM, Kniss K, Burns E, Rowe T, Foust A, Jasso G, Merced-Morales A, Davis CT, Jang Y, Jones J, Daly P, Gubareva L, Barnes J, Kondor R, Sessions W, Smith C, Wentworth DE, Garg S, Havers FP, Fry AM, Hall AJ, Brammer L, Silk BJ. Changes in influenza and other respiratory virus activity during the COVID-19 pandemic - United States, 2020–2021. MMWR Morb Mortal Wkly Rep 2021;70:1013–9. doi: 10.15585/mmwr.mm7029a1
- Brueggemann AB, Jansen van Rensburg MJ, Shaw D, McCarthy ND, Jolley KA, Maiden MCJ, van der Linden MPG, Amin-Chowdhury Z, Bennett DE, Borrow R, Brandileone MC, Broughton K, Campbell R, Cao B, Casanova C, Choi EH, Chu YW, Clark SA, Claus H, Coelho J, Corcoran M, Cottrell S, Cunney RJ, Dalby T, Davies H, de Gouveia L, Deghmane AE, Demczuk W, Desmet S, Drew RJ, du Plessis M, Erlendsdottir H, Fry NK, Fuursted K, Gray SJ, Henriques-Normark B, Hale T, Hilty M, Hoffmann S, Humphreys H, Ip M, Jacobsson S, Johnston J, Kozakova J, Kristinsson KG, Krizova P, Kuch A, Ladhani SN, Lâm TT, Lebedova V, Lindholm L, Litt DJ, Martin I, Martiny D, Mattheus W, McElligott M, Meehan M, Meiring S, Mölling P, Morfeldt E, Morgan J, Mulhall RM, Muñoz-Almagro C, Murdoch DR, Murphy J, Musilek M, Mzabi A, Perez-Argüello A, Perrin M, Perry M, Redin A, Roberts R, Roberts M, Rokney A, Ron M, Scott KJ, Sheppard CL, Siira L, Skoczyńska A, Sloan M, Slotved HC, Smith AJ, Song JY, Taha MK, Toropainen M, Tsang D, Vainio A, van Sorge NM, Varon E, Vlach J, Vogel U, Vohrnova S, von Gottberg A, Zanella RC, Zhou F. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. Lancet Digit Health 2021;3(6):e360–70. doi: 10.1016/S2589-7500(21)00077-7. Erratum in: Lancet Digit Health 2021;3(7):e413. doi: 10.1016/S2589-7500(21)00103-5
- Lobie TA, Roba AA, Booth JA, Kristiansen KI, Aseffa A, Skarstad K, Bjørås M. Antimicrobial resistance: A challenge awaiting the post-COVID-19 era. Int J Infect Dis 2021;111:322–5. doi: 10.1016/j.ijid.2021.09.003
DOI: https://doi.org/10.2478/aiht-2026-77-4130 | Journal eISSN: 1848-6312 (formerly 0004-1254) | Journal ISSN: 0004-1254
Language: English, Croatian
Page range: 160 - 168
Submitted on: Apr 1, 2026
Accepted on: Sep 1, 2026
Published on: Sep 25, 2026
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Related subjects:
© 2026 Marija Špelić, Vladimir Krajinović, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution 4.0 License.